miércoles, 6 de enero de 2021

SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply - The Lancet Rheumatology

SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario